Projects per year
Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Specialized Health
Fingerprint
Dive into the research topics where Sanja Sever is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Active
-
Institute for Drug Discovery, Phase 2
Sever, S. (PI)
Sealy and Smith Foundation ( Award # )
12/8/24 → 8/31/29
Project: Research project
-
Institute for Drug Discovery
Sever, S. (PI)
Sealy and Smith Foundation ( Award # )
10/31/24 → 8/30/29
Project: Research project
-
Role of proteolytic suPAR fragment in insulin dependent diabetes and kidney disease
Sever, S. (PI)
National Institute of Diabetes and Digestive and Kidney Diseases ( Award #5R01DK13336404)
5/3/24 → 4/30/28
Project: Research project
-
The role of suPAR and related proteins in kidney, heart diseases, and diabetes
Reiser, J., Hayek, S. S. & Sever, S., Jan 2 2026, In: The Journal of clinical investigation. 136, 1Research output: Contribution to journal › Review article › peer-review
2 Link opens in a new tab Scopus citations -
Recessive variants in the intergenic NOS1AP-C1orf226 locus cause monogenic kidney disease responsive to anti-proteinuric treatment
Nephrotic Syndrome Study Network (NEPTUNE), Dec 2025, In: Nature communications. 16, 1, 10654.Research output: Contribution to journal › Article › peer-review
Open Access -
Treatment of Podocytopathies Risky Business and Our Personal Journey
Sever, S. & Reiser, J., Nov 1 2024, In: Journal of the American Society of Nephrology. 35, 11, p. 1600-1602 3 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease
Zhu, K., Mukherjee, K., Wei, C., Hayek, S. S., Collins, A., Gu, C., Corapi, K., Altintas, M. M., Wang, Y., Waikar, S. S., Bianco, A. C., Koch, A., Tacke, F., Reiser, J. & Sever, S., 2023, In: Science Translational Medicine. 15, 714, eabq6492.Research output: Contribution to journal › Article › peer-review
4 Link opens in a new tab Scopus citations -
The small GTPase regulatory protein Rac1 drives podocyte injury independent of cationic channel protein TRPC5
Polat, O. K., Isaeva, E., Sudhini, Y. R., Knott, B., Zhu, K., Noben, M., Suresh Kumar, V., Endlich, N., Mangos, S., Reddy, T. V., Samelko, B., Wei, C., Altintas, M. M., Dryer, S. E., Sever, S., Staruschenko, A. & Reiser, J., Jun 2023, In: Kidney International. 103, 6, p. 1056-1062 7 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Link opens in a new tab Scopus citations